Top Stories
-
Columbia-led clinical trial addresses important barrier to opioid use disorder treatment.
Topic
-
Ryan Lawrence, MD, director of the Comprehensive Psychiatric Emergency Program, discusses what individuals can expect during an ER visit.
Topic
-
Columbia-led study hold promise for helping people find therapies that work.
Topic
-
Studies indicate that 29% to 46% of patients diagnosed with major depressive disorder show partial or no response to treatments.
Topic
Latest News
-
Source:
Fox NewsJuly 30, 2019“This has been described in the literature going back to the Civil War,” Dr. Jeffrey Lieberman said. “It was called ‘Soldier's Heart’ because one of the features of PTSD was a rapid heartbeat.
Topic
-
Source:
MD MagazineJune 26, 2019Dr. Elias Dakwar sought proof of the suggestion that concentrated doses of ketamine may help reduce vulnerabilities associated with cocaine use, and improve the likelihood of relapse prevention.
Topic
-
Source:
MedscapeJune 10, 2019“As we treat more people with ketamine, an unfortunate side effect of that is more exposure, which means that we're going to create more ketamine addicts,” said Dr. Drew Ramsey.
Topic
-
Source:
Brooklyn EagleApril 17, 2019Dr. J. John Mann says while there are clear short-term benefits to ketamine, its long-term effects, its abuse potential and the optimal number of treatments a patient should receive are still unknown.
Topic
- April 15, 2019
Columbia Psychiatrists suggest that researchers, pharmaceutical companies, and the FDA reconsider placebo-controlled, relapse prevention studies in schizophrenia.
-
Source:
JAMAApril 10, 2019Dr. Jeffrey Lieberman and colleagues conclude that the time has come to cease the use of placebo in relapse prevention studies and encourage the use of active comparators.
- April 4, 2019
Dr. Christine Ann Denny’s laboratory is interested in the molecular mechanisms underlying learning and memory.
Topic
-
Source:
MD MagazineMarch 8, 2019Dr. Jeffrey Lieberman’s concerns about whether dosing strategies for ketamine have been properly set by clinical trials are mentioned in this Q&A.
Topic
-
Source:
NewsDayFebruary 23, 2019Schizophrenia and other psychotic disorders affect each person differently and vary in severity, said Dr. Lisa Dixon.
-
Source:
HealioFebruary 21, 2019“The effectiveness of combinations of antipsychotic medications remains unclear; reviews of this treatment strategy agree on the need for further investigation,” Dr. T. Scott Stroup and team wrote.
